Interestingly, Oroxylin A, a flavonoid, was found to inhibit SHCBP1 expression in synovial sarcoma cells, affecting the activity of the NF-κB signaling pathway and regulating the expression of inflammatory factors that have an inhibitory effect on tumor cell proliferation [40]. Here, NFKB1 is linked to synovial sarcoma.